Equities researchers at StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the medical device company’s stock.
Avinger Stock Down 3.5 %
NASDAQ AVGR opened at $0.95 on Tuesday. The stock’s 50-day simple moving average is $1.19 and its two-hundred day simple moving average is $2.22. Avinger has a twelve month low of $0.90 and a twelve month high of $6.55. The company has a market capitalization of $1.62 million, a price-to-earnings ratio of -0.05 and a beta of 1.17.
Avinger (NASDAQ:AVGR – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The company had revenue of $1.85 million during the quarter, compared to the consensus estimate of $2.55 million. On average, equities analysts expect that Avinger will post -4.69 earnings per share for the current fiscal year.
Institutional Trading of Avinger
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
See Also
- Five stocks we like better than Avinger
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- How to Start Investing in Real Estate
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.